Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Oric Pharmaceuticals (ORIC)
NASDAQ:ORIC
Oric Pharmaceuticals (ORIC) Stock Price & Analysis
266 Followers
ORIC Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$4.89 - $16.65
Previous Close$10.75
Volume502.98K
Average Volume (3M)591.89K
Market Cap
$724.29M
Enterprise Value$516.10M
Total Cash (Recent Filing)$208.19M
Total Debt (Recent Filing)$0.00
Price to Earnings (P/E)-5.5
Beta1.27
Next Earnings
May 06, 2024EPS Estimate
-$0.42Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-1.97
Shares Outstanding67,375,847
10 Day Avg. Volume474,919
30 Day Avg. Volume591,893
Standard Deviation0.24
R-Squared0.04
Alpha0.00003
Financial Highlights & Ratios
Price to Book (P/B)3.30
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)-7.60
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit10.00T>
Enterprise Value/Ebitda-4.88
Forecast
1Y Price Target
$20.20Price Target Upside87.91% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering6
Oric Pharmaceuticals News
Ownership Overview
22.21% Insiders
14.12% Mutual Funds
55.22% Other Institutional Investors
8.45% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
ORIC FAQ
What was Oric Pharmaceuticals’s price range in the past 12 months?
Oric Pharmaceuticals lowest stock price was $4.89 and its highest was $16.65 in the past 12 months.
What is Oric Pharmaceuticals’s market cap?
Currently, no data Available
When is Oric Pharmaceuticals’s upcoming earnings report date?
Oric Pharmaceuticals’s upcoming earnings report date is May 06, 2024 which is in 17 days.
How were Oric Pharmaceuticals’s earnings last quarter?
Oric Pharmaceuticals released its earnings results on Mar 11, 2024. The company reported -$0.49 earnings per share for the quarter, missing the consensus estimate of -$0.478 by -$0.012.
Is Oric Pharmaceuticals overvalued?
According to Wall Street analysts Oric Pharmaceuticals’s price is currently Undervalued.
Does Oric Pharmaceuticals pay dividends?
Oric Pharmaceuticals does not currently pay dividends.
What is Oric Pharmaceuticals’s EPS estimate?
Oric Pharmaceuticals’s EPS estimate is -$0.42.
How many shares outstanding does Oric Pharmaceuticals have?
Oric Pharmaceuticals has 67,375,850 shares outstanding.
What happened to Oric Pharmaceuticals’s price movement after its last earnings report?
Oric Pharmaceuticals reported an EPS of -$0.49 in its last earnings report, missing expectations of -$0.478. Following the earnings report the stock price went down -4.47%.
Which hedge fund is a major shareholder of Oric Pharmaceuticals?
Among the largest hedge funds holding Oric Pharmaceuticals’s share is Invus Financial Advisors, LLC. It holds Oric Pharmaceuticals’s shares valued at 9M.
---
Oric Pharmaceuticals Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$20.20 (87.91% Upside)
$20.20 (87.91% Upside)
Blogger Sentiment
Bullish
ORIC Sentiment 100%
Sector Average 71%
Sector Average 71%
Hedge Fund Trend
Increased
By 574.0 Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Negative
Last 7 Days ▼ 1.9%
Last 30 Days ▼ 10.9%
Last 30 Days ▼ 10.9%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
85.66%
12-Months-Change
Fundamentals
Return on Equity
-45.11%
Trailing 12-Months
Asset Growth
1.73%
Trailing 12-Months
Company Description
Oric Pharmaceuticals
ORIC Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It has a pipeline of therapies designed to counter resistance mechanisms in cancer by leveraging its expertise within three specific areas: hormone-dependent cancers, precision oncology, and key tumor dependencies. The company has product candidates namely, ORIC-101 and ORIC-533.
---
ORIC Stock 12 Months Forecast
Average Price Target
$20.20
▲(87.91% Upside)
Technical Analysis
Best Analysts Covering ORIC
1 Year
1 Year Success Rate
6/12 ratings generated profit
1 Year Average Return
+29.88%
reiterated a buy rating 24 days ago
Copying Anupam Rama's trades and holding each position for 1 Year would result in 50.00% of your transactions generating a profit, with an average return of +29.88% per trade.
---